126,990 Shares in Sotera Health (NASDAQ:SHC) Bought by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D bought a new position in Sotera Health (NASDAQ:SHC - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 126,990 shares of the company's stock, valued at approximately $2,121,000.

A number of other hedge funds also recently made changes to their positions in the company. Wedmont Private Capital raised its stake in Sotera Health by 6.5% during the third quarter. Wedmont Private Capital now owns 10,915 shares of the company's stock valued at $169,000 after purchasing an additional 664 shares in the last quarter. First Citizens Bank & Trust Co. raised its position in shares of Sotera Health by 5.0% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company's stock valued at $239,000 after buying an additional 677 shares in the last quarter. CWM LLC lifted its holdings in shares of Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company's stock valued at $25,000 after acquiring an additional 993 shares during the last quarter. Swiss National Bank lifted its holdings in shares of Sotera Health by 0.5% in the 1st quarter. Swiss National Bank now owns 195,900 shares of the company's stock valued at $2,353,000 after acquiring an additional 1,000 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock worth $50,000 after acquiring an additional 1,660 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on SHC shares. Citigroup raised their price objective on Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a research note on Wednesday, November 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $17.00 price objective on shares of Sotera Health in a research note on Tuesday, August 6th. Finally, Barclays lifted their target price on Sotera Health from $14.00 to $17.00 and gave the company an "overweight" rating in a research note on Tuesday, August 6th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $16.50.

Insider Activity at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the sale, the director now directly owns 49,215,301 shares in the company, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 55.12% of the stock is owned by company insiders.

Sotera Health Stock Performance

NASDAQ:SHC traded down $0.48 during trading hours on Friday, hitting $14.51. 640,395 shares of the company were exchanged, compared to its average volume of 1,292,696. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The company's 50 day moving average price is $15.96 and its 200-day moving average price is $13.85. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The stock has a market capitalization of $4.11 billion, a price-to-earnings ratio of 58.00 and a beta of 2.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The business had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. Sotera Health's quarterly revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.18 EPS. As a group, research analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.